全球药物研发服务市场（2023-2030）：按类型（小分子、聚合物）和最终用户（製药和生物技术公司、学术机构）分類的规模、份额、成长分析和预测

Global Drug Discovery Services Market Size, Share, Growth Analysis, By Type(Small molecules and Large molecules), By End-User(Pharmaceutical & Biotechnology companies and Academic Institutes) - Industry Forecast 2023-2030

出版日期: 2023年10月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

根据预测，全球药物研发服务市场规模将从2021年的32.6亿美元和2022年的35亿美元成长到2030年的66亿美元，预测期内年复合成长率为7.3%。

全球药物研发服务市场的驱动因素

对各种治疗目的的新疗法的需求不断增加

对慢性病新疗法的需求不断增长以及全球医疗保健行业的进步预计将成为市场扩张的主要驱动力。随着製药和生物製药公司将研发活动委託给CRO，CRO提供研发服务并创建参与模型以最大限度地提高研发效率。此外，慢性病负担的增加迫使政府和製药公司寻求解决方案并增加对临床试验的投资。由于这些原因，对药物研发服务的需求预计将会扩大。

全球药物研发服务市场趋势

市场正在见证几个正在塑造其前景的关键市场趋势。首先，随着製药和生技公司寻求专业服务提供者来进行药物研发活动，外包显着增加。透过这样做，公司可以专注于自己的核心竞争力，同时利用专业知识、尖端技术和具有成本效益的解决方案。另一个重要趋势是製药公司和 CRO 之间转向合作关係。这种伙伴关係能够共用资源、专业知识和风险，促进创新并加速药物研发过程。技术进步在药物研发服务市场中发挥重要作用。高通量筛选、人工智慧和基因组学等技术正在彻底改变药物研发过程，以便更快、更有效地识别和最佳化候选药物研发。

本报告调查了全球药物研发服务市场，并提供了市场概况、影响市场的各种因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及按各个细分市场和地区进行的细分。总结了主要企业的细分、竞争形势和概况。

执行摘要
调查方法
母市场分析
- 市场概况
- 市场规模
- 市场动态
  - 促进因素
  - 机会
  - 抑制因素
  - 任务
关键市场洞察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- 启动分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 重点投资分析
- 关键成功因素
- 竞争程度
- 市场动态及展望
  - 市场动态
    - 促进因素
    - 机会
    - 抑制因素
    - 任务
- 法规状况
- 波特的分析
- Skyquest 对未来颠覆的独家见解
全球药物研发服务市场：按类型
- 市场概况
- 低分子
- 高分子
全球药物研发服务市场：按最终用户划分
- 市场概况
- 製药和生物技术公司
- 学术机构
全球药物研发服务市场：按地区
- 市场概况
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东/非洲
竞争形势
- 前5名企业对比
- 主要企业市场地位
- 主要企业的招募策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率
主要企业简介
- General Electric
- Eurofins Scientific
- PPD Inc.
- Syngene International Limited
- Wuxi AppTec
- Frontage Labs
- Galapagos NV
- Aurigene Discovery Technologies
- Genscript
- Domainex
- WIL Research Laboratories LLC
- Shanghai Medicilon, Inc.
- Labcorp Drug Development
- Jubilant Biosys Ltd.
- Evotec
- Shanghai ChemPartner
- Charles River Laboratories
- Merck & Co. Inc.
- Thermo Fisher Scientific Inc.
- TCG Lifesciences Pvt Ltd.

简介目录

Product Code: SQMIG35J2059

Global Drug Discovery Services Market size was valued at USD 3.26 billion in 2021 and is poised to grow from USD 3.5 billion in 2022 to USD 6.6 billion by 2030, growing at a CAGR of 7.3% during the forecast period (2023-2030).

The Global Drug Discovery Services Market is a dynamic and rapidly evolving sector within the pharmaceutical and biotechnology industries. It encompasses a wide range of services and solutions aimed at discovering and developing new drugs to address various diseases and medical conditions. Drug discovery is a complex and resource-intensive process that involves the identification and validation of potential drug targets, the development of drug candidates, and rigorous testing for safety and efficacy. This process typically takes several years and requires significant investment in research and development (R&D). To streamline and expedite this process, pharmaceutical and biotechnology companies often seek the assistance of specialized drug discovery service providers. These service providers offer a diverse range of services to support the drug discovery process. They utilize advanced technologies, expertise, and infrastructure to accelerate the identification and optimization of potential drug candidates. These services may include target identification and validation, hit identification and lead optimization, medicinal chemistry, in vitro and in vivo testing, preclinical development, and early-phase clinical trials. In conclusion, the Global market plays a vital role in the drug development process, providing essential support and expertise to pharmaceutical and biotechnology companies. With the increasing demand for innovative therapies and the need for accelerated drug development, this market is expected to experience substantial growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Services Market Segmental Analysis

Global Drug Discovery Services Market is segmented by type, end-user, and region. Based on type, the market can be segmented into small molecules and large molecules. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies and academic institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Drug Discovery Services Market

Rising demand for novel therapies for various therapeutic purposes

Drug-finding services rising demand for novel treatments for chronic diseases and advancements in the global healthcare industry are predicted to be the main drivers of market expansion. Pharmaceutical and biopharmaceutical businesses still contract out their research and development (R&D) activities to CROs, which offer R&D services and create engagement models to maximise R&D efficiency. Governments and pharmaceutical corporations are being forced to look for solutions and boost their investment in clinical trials as a result of the increased burden of chronic diseases. As a result, there will be a greater need for drug discovery services.

Restraints in the Global Drug Discovery Services Market

High cost of drug molecules and lack of skilled labour

The two biggest challenges facing the market will be a scarcity of trained labour and a high failure rate for target medication molecules. Millions of dollars are spent on preclinical research to find a molecule or create a medicine, which drives up the price of drug development.

Market Trends of the Global Drug Discovery Services Key

Global Drug Discovery Services Market is experiencing several key market trends that are shaping its landscape. Firstly, there is a noticeable increase in outsourcing as pharmaceutical and biotech companies seek specialized service providers to handle their drug discovery activities. By doing so, companies can access expertise, advanced technologies, and cost-effective solutions while focusing on their core competencies. Another significant trend is the shift towards collaborative partnerships between pharmaceutical companies and contract research organizations (CROs). These partnerships allow for shared resources, expertise, and risk-sharing, fostering innovation and accelerating the drug discovery process. Technological advancements play a vital role in the drug discovery services market. Technologies such as high-throughput screening, artificial intelligence, and genomics are revolutionizing the process, enabling faster and more efficient identification and optimization of drug candidates.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Drug Discovery Services Market by Type
- Market Overview
- Small molecules and Large molecules
Global Drug Discovery Services Market by End-User
- Market Overview
- Pharmaceutical & Biotechnology companies and Academic Institutes
Global Drug Discovery Services Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- General Electric (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eurofins Scientific (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- PPD Inc. (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Syngene International Limited (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Wuxi AppTec (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Frontage Labs (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Galapagos NV (Belgium)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Aurigene Discovery Technologies (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Genscript (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Domainex (U.K.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- WIL Research Laboratories LLC (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Shanghai Medicilon, Inc. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Labcorp Drug Development (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Jubilant Biosys Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Evotec (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Shanghai ChemPartner (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Charles River Laboratories (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck & Co. Inc. (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Thermo Fisher Scientific Inc. (U.S.)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- TCG Lifesciences Pvt Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments